---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-009735"
form_type: "8-K/A"
ticker: "OPK"
cik: "0000944809"
company_name: "OPKO HEALTH, INC."
filed_at: "2024-03-28T23:59:59+00:00"
generated_at: "2026-06-04T06:53:29.156737+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# OPKO files 8-K/A to update investor presentation after BioReference asset sale to LabCorp

## Summary
- Asset Purchase Agreement with LabCorp for BioReference Health, LLC signed March 27, 2024.
- This amendment replaces the January investor presentation with a March 27, 2024 version.
- Exhibit 2.1 (Asset Purchase Agreement) filed with schedules omitted; no deal value disclosed.
- No financial or operational details from the updated presentation available in this filing.

## SEC filing metadata
- accession: 0001437749-24-009735
- form_type: 8-K/A
- ticker: OPK
- cik: 0000944809
- company_name: OPKO HEALTH, INC.
- filed_at: 2024-03-28T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/944809/000143774924009735/0001437749-24-009735-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/944809/000143774924009735/opk20240328_8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-009735
- JSON: https://secwatch.observer/filing/0001437749-24-009735.json
- Plain text: https://secwatch.observer/filing/0001437749-24-009735.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.